Xbrane Biopharma AB (publ)(OM:XBRANE) dropped from S&P Global BMI Index
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1904 SEK | -4.80% | -12.06% | -98.10% |
05-02 | Xbrane Biopharma AB Appoints Kristoffer Bissessar Was Elected as New Director | CI |
04-22 | Transcript : Xbrane Biopharma AB - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-98.10% | 26.71M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- XBRANE Stock
- News Xbrane Biopharma AB
- Xbrane Biopharma AB(OM: XBRANE) dropped from S&P Global BMI Index